ID   ST17B_HUMAN             Reviewed;         372 AA.
AC   O94768;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   12-OCT-2022, entry version 186.
DE   RecName: Full=Serine/threonine-protein kinase 17B;
DE            EC=2.7.11.1;
DE   AltName: Full=DAP kinase-related apoptosis-inducing protein kinase 2;
GN   Name=STK17B; Synonyms=DRAK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF LYS-62.
RC   TISSUE=Liver, and Placenta;
RX   PubMed=9786912; DOI=10.1074/jbc.273.44.29066;
RA   Sanjo H., Kawai T., Akira S.;
RT   "DRAKs, novel serine/threonine kinases related to death-associated protein
RT   kinase that trigger apoptosis.";
RL   J. Biol. Chem. 273:29066-29071(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-320.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates myosin light chains (By similarity). Acts as a
CC       positive regulator of apoptosis. {ECO:0000250,
CC       ECO:0000269|PubMed:9786912}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with CHP1; the interaction induces CHP1 to
CC       translocate from the Golgi to the nucleus. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9786912}. Cell
CC       membrane {ECO:0000250}. Endoplasmic reticulum-Golgi intermediate
CC       compartment {ECO:0000250}. Note=Colocalizes with STK17B at the plasma
CC       membrane. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta, lung, pancreas. Lower
CC       levels in heart, brain, liver, skeletal muscle and kidney.
CC       {ECO:0000269|PubMed:9786912}.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. DAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB011421; BAA34127.1; -; mRNA.
DR   EMBL; BC016040; AAH16040.1; -; mRNA.
DR   CCDS; CCDS2315.1; -.
DR   RefSeq; NP_004217.1; NM_004226.3.
DR   RefSeq; XP_011510470.1; XM_011512168.2.
DR   RefSeq; XP_011510471.1; XM_011512169.1.
DR   RefSeq; XP_011510472.1; XM_011512170.1.
DR   PDB; 3LM0; X-ray; 2.35 A; A=25-329.
DR   PDB; 3LM5; X-ray; 2.29 A; A=25-329.
DR   PDB; 6QF4; X-ray; 2.50 A; A=18-329.
DR   PDB; 6Y6F; X-ray; 1.98 A; A=25-329.
DR   PDB; 6Y6H; X-ray; 1.95 A; A=25-329.
DR   PDB; 6ZJF; X-ray; 1.75 A; A=25-329.
DR   PDB; 7AKG; X-ray; 2.08 A; A=25-329.
DR   PDBsum; 3LM0; -.
DR   PDBsum; 3LM5; -.
DR   PDBsum; 6QF4; -.
DR   PDBsum; 6Y6F; -.
DR   PDBsum; 6Y6H; -.
DR   PDBsum; 6ZJF; -.
DR   PDBsum; 7AKG; -.
DR   AlphaFoldDB; O94768; -.
DR   SMR; O94768; -.
DR   BioGRID; 114684; 37.
DR   IntAct; O94768; 27.
DR   STRING; 9606.ENSP00000263955; -.
DR   BindingDB; O94768; -.
DR   ChEMBL; CHEMBL3980; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB04216; Quercetin.
DR   DrugCentral; O94768; -.
DR   GlyGen; O94768; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O94768; -.
DR   PhosphoSitePlus; O94768; -.
DR   BioMuta; STK17B; -.
DR   CPTAC; CPTAC-1034; -.
DR   EPD; O94768; -.
DR   jPOST; O94768; -.
DR   MassIVE; O94768; -.
DR   PaxDb; O94768; -.
DR   PeptideAtlas; O94768; -.
DR   PRIDE; O94768; -.
DR   ProteomicsDB; 50432; -.
DR   Antibodypedia; 19872; 435 antibodies from 43 providers.
DR   DNASU; 9262; -.
DR   Ensembl; ENST00000263955.9; ENSP00000263955.4; ENSG00000081320.11.
DR   Ensembl; ENST00000409228.5; ENSP00000386853.1; ENSG00000081320.11.
DR   GeneID; 9262; -.
DR   KEGG; hsa:9262; -.
DR   MANE-Select; ENST00000263955.9; ENSP00000263955.4; NM_004226.4; NP_004217.1.
DR   CTD; 9262; -.
DR   DisGeNET; 9262; -.
DR   GeneCards; STK17B; -.
DR   HGNC; HGNC:11396; STK17B.
DR   HPA; ENSG00000081320; Group enriched (bone marrow, lymphoid tissue).
DR   MIM; 604727; gene.
DR   neXtProt; NX_O94768; -.
DR   OpenTargets; ENSG00000081320; -.
DR   PharmGKB; PA36204; -.
DR   VEuPathDB; HostDB:ENSG00000081320; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000154014; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; O94768; -.
DR   OMA; FYMLESK; -.
DR   OrthoDB; 1156450at2759; -.
DR   PhylomeDB; O94768; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; O94768; -.
DR   SignaLink; O94768; -.
DR   SIGNOR; O94768; -.
DR   BioGRID-ORCS; 9262; 9 hits in 1116 CRISPR screens.
DR   ChiTaRS; STK17B; human.
DR   EvolutionaryTrace; O94768; -.
DR   GenomeRNAi; 9262; -.
DR   Pharos; O94768; Tchem.
DR   PRO; PR:O94768; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O94768; protein.
DR   Bgee; ENSG00000081320; Expressed in epithelium of nasopharynx and 172 other tissues.
DR   ExpressionAtlas; O94768; baseline and differential.
DR   Genevisible; O94768; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   CDD; cd14198; STKc_DRAK2; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR042763; ST17B_STKc.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Cell membrane; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..372
FT                   /note="Serine/threonine-protein kinase 17B"
FT                   /id="PRO_0000086706"
FT   DOMAIN          33..293
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          305..362
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        333..362
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        158
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         39..47
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         62
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   VARIANT         320
FT                   /note="S -> F (in dbSNP:rs34740616)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041147"
FT   MUTAGEN         62
FT                   /note="K->A: Loss of activity and of apoptotic function."
FT                   /evidence="ECO:0000269|PubMed:9786912"
FT   HELIX           25..31
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          32..41
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          43..52
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   TURN            53..55
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          58..68
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           74..86
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          96..101
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          103..111
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           118..122
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           124..129
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           132..151
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           161..163
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   TURN            169..172
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:3LM5"
FT   HELIX           194..196
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           204..207
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           214..230
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           240..249
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           256..259
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           264..273
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           284..288
FT                   /evidence="ECO:0007829|PDB:6ZJF"
FT   HELIX           291..293
FT                   /evidence="ECO:0007829|PDB:6ZJF"
SQ   SEQUENCE   372 AA;  42344 MW;  7E69FFAED6DC1FF3 CRC64;
     MSRRRFDCRS ISGLLTTTPQ IPIKMENFNN FYILTSKELG RGKFAVVRQC ISKSTGQEYA
     AKFLKKRRRG QDCRAEILHE IAVLELAKSC PRVINLHEVY ENTSEIILIL EYAAGGEIFS
     LCLPELAEMV SENDVIRLIK QILEGVYYLH QNNIVHLDLK PQNILLSSIY PLGDIKIVDF
     GMSRKIGHAC ELREIMGTPE YLAPEILNYD PITTATDMWN IGIIAYMLLT HTSPFVGEDN
     QETYLNISQV NVDYSEETFS SVSQLATDFI QSLLVKNPEK RPTAEICLSH SWLQQWDFEN
     LFHPEETSSS SQTQDHSVRS SEDKTSKSSC NGTCGDREDK ENIPEDSSMV SKRFRFDDSL
     PNPHELVSDL LC
//
